scholarly journals Structure of the 5th transmembrane segment of the Na,K-ATPase α subunit: a cysteine-scanning mutagenesis study

FEBS Letters ◽  
2000 ◽  
Vol 482 (1-2) ◽  
pp. 144-148 ◽  
Author(s):  
Saı̈da Guennoun ◽  
Jean-Daniel Horisberger
FEBS Letters ◽  
1999 ◽  
Vol 461 (3) ◽  
pp. 315-318 ◽  
Author(s):  
Satoko Konishi ◽  
Shinobu Iwaki ◽  
Tomomi Kimura-Someya ◽  
Akihito Yamaguchi

1998 ◽  
Vol 273 (9) ◽  
pp. 5243-5247 ◽  
Author(s):  
Tomomi Kimura ◽  
Yasuko Shiina ◽  
Tetsuo Sawai ◽  
Akihito Yamaguchi

2000 ◽  
Vol 182 (4) ◽  
pp. 1001-1007 ◽  
Author(s):  
Yukako Asai ◽  
Tomokazu Shoji ◽  
Ikuro Kawagishi ◽  
Michio Homma

ABSTRACT The sodium-driven motor consists of the products of at least four genes, pomA, pomB, motX, andmotY, in Vibrio alginolyticus. PomA and PomB, which are homologous to the MotA and MotB components of proton-driven motors, have four transmembrane segments and one transmembrane segment, respectively, and are thought to form an ion channel. In PomA, two periplasmic loops were predicted at positions 21 to 36 between membrane segments 1 and 2 (loop1-2) and at positions 167 to 180 between membrane segments 3 and 4 (loop3-4). To characterize the two periplasmic loop regions, which may have a role as an ion entrance for the channel, we carried out cysteine-scanning mutagenesis. The T186 residue in the fourth transmembrane segment and the D71, D148, and D202 residues in the predicted cytoplasmic portion of PomA were also replaced with Cys. Only two mutations, M179C and T186C, conferred a nonmotile phenotype. Many mutations in the periplasmic loops and all of the cytoplasmic mutations did not abolish motility, though the five successive substitutions from M169C to K173C of loop3-4 impaired motility. In some mutants that retained substantial motility, motility was inhibited by the thiol-modifying reagents dithionitrobenzoic acid and N-ethylmaleimide. The profiles of inhibition by the reagents were consistent with the membrane topology predicted from the hydrophobicity profiles. Furthermore, from the profiles of labeling by biotin maleimide, we predicted more directly the membrane topology of loop3-4. None of the loop1-2 residues were labeled, suggesting that the environments around the two loops are very different. A few of the mutations were characterized further. The structure and function of the loop regions are discussed.


2003 ◽  
Vol 278 (51) ◽  
pp. 51833-51840 ◽  
Author(s):  
Ashutosh A. Kulkarni ◽  
Ian S. Haworth ◽  
Tomomi Uchiyama ◽  
Vincent H. L. Lee

2006 ◽  
Vol 399 (2) ◽  
pp. 351-359 ◽  
Author(s):  
Tip W. Loo ◽  
M. Claire Bartlett ◽  
David M. Clarke

P-gp (P-glycoprotein; ABCB1) protects us by transporting a broad range of structurally unrelated compounds out of the cell. Identifying the regions of P-gp that make up the drug-binding pocket is important for understanding the mechanism of transport. The common drug-binding pocket is at the interface between the transmembrane domains of the two homologous halves of P-gp. It has been shown in a previous study [Loo, Bartlett and Clarke (2006) Biochem. J. 396, 537–545] that the first transmembrane segment (TM1) contributed to the drug-binding pocket. In the present study, we used cysteine-scanning mutagenesis, reaction with an MTS (methanethiosulfonate) thiol-reactive analogue of verapamil (termed MTS–verapamil) and cross-linking analysis to test whether the equivalent transmembrane segment (TM7) in the C-terminal-half of P-gp also contributed to drug binding. Mutation of Phe728 to cysteine caused a 4-fold decrease in apparent affinity for the drug substrate verapamil. Mutant F728C also showed elevated ATPase activity (11.5-fold higher than untreated controls) after covalent modification with MTS–verapamil. The activity returned to basal levels after treatment with dithiothreitol. The substrates, verapamil and cyclosporin A, protected the mutant from labelling with MTS–verapamil. Mutant F728C could be cross-linked with a homobifunctional thiol-reactive cross-linker to cysteines I306C(TM5) and F343C(TM6) that are predicted to line the drug-binding pocket. Disulfide cross-linking was inhibited by some drug substrates such as Rhodamine B, calcein acetoxymethyl ester, cyclosporin, verapamil and vinblastine or by vanadate trapping of nucleotides. These results indicate that TM7 forms part of the drug-binding pocket of P-gp.


Sign in / Sign up

Export Citation Format

Share Document